TY  - JOUR
AU  - Bohlken, Jens
AU  - Kostev, Karel
AU  - Michalowsky, Bernhard
TI  - Alzheimer-Demenz und Antidementiva-Verordnungen 2010–2021 in 357 Hausarzt- und 71 Facharztpraxen  -  Alzheimer's Dementia and Anti-Dementia Medication Prescriptions 2010-2021 in 357 GP Practices and 71 Specialist Practices
JO  - Psychiatrische Praxis
VL  - 52
IS  - 1
SN  - 0303-4259
CY  - Stuttgart
PB  - Thieme
M1  - DZNE-2025-00139
SP  - 44 - 47
PY  - 2025
AB  - The predicted prevalence of people with dementia (PWD) in Germany has risen to 1.8 million since 2010. In the near future, we will see the approval of antibody therapies. The study aims to demonstrate the recent anti-dementia medication prescriptions and diagnosis prevalence.Data from 357 general practitioner (GP) and 71 specialist practices (SP) (1.1 Mio. patients) were analyzed to demonstrate the prevalence of dementia diagnoses and anti-dementia drug prescriptions between 2010 and 2021.The diagnosis prevalence of PWD (Alzheimer's dementia) remained relatively constant in GP practices at 1.0-1.3
KW  - Alzheimer Disease: drug therapy
KW  - Alzheimer Disease: epidemiology
KW  - Alzheimer Disease: diagnosis
KW  - Humans
KW  - Germany
KW  - Aged
KW  - General Practice: statistics & numerical data
KW  - Male
KW  - Female
KW  - Aged, 80 and over
KW  - Practice Patterns, Physicians': statistics & numerical data
KW  - Forecasting
KW  - Drug Prescriptions: statistics & numerical data
KW  - Cross-Sectional Studies
KW  - Dementia: drug therapy
KW  - Dementia: epidemiology
KW  - Nootropic Agents: therapeutic use
KW  - Nootropic Agents (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:39384316
DO  - DOI:10.1055/a-2370-1933
UR  - https://pub.dzne.de/record/275906
ER  -